Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $12.1 million.

  • Sanara MedTech's Receivables - Net rose 917.04% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year increase of 917.04%. This contributed to the annual value of $12.4 million for FY2024, which is 4641.73% up from last year.
  • As of Q3 2025, Sanara MedTech's Receivables - Net stood at $12.1 million, which was up 917.04% from $12.0 million recorded in Q2 2025.
  • Sanara MedTech's 5-year Receivables - Net high stood at $12.4 million for Q4 2024, and its period low was $2.1 million during Q3 2021.
  • Moreover, its 5-year median value for Receivables - Net was $7.1 million (2023), whereas its average is $7.3 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first soared by 16262.17% in 2022, then surged by 917.04% in 2025.
  • Over the past 5 years, Sanara MedTech's Receivables - Net (Quarter) stood at $2.9 million in 2021, then surged by 137.88% to $6.8 million in 2022, then rose by 24.53% to $8.5 million in 2023, then skyrocketed by 46.42% to $12.4 million in 2024, then dropped by 2.6% to $12.1 million in 2025.
  • Its Receivables - Net was $12.1 million in Q3 2025, compared to $12.0 million in Q2 2025 and $11.9 million in Q1 2025.